| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.0095 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |